272 related articles for article (PubMed ID: 34350641)
1. The emerging role of cannabidiol (CBD) products; a survey exploring the public's use and perceptions of CBD.
Bhamra SK; Desai A; Imani-Berendjestanki P; Horgan M
Phytother Res; 2021 Oct; 35(10):5734-5740. PubMed ID: 34350641
[TBL] [Abstract][Full Text] [Related]
2. Young adults' knowledge, perceptions and use of cannabidiol products: a mixed-methods study.
Wysota CN; Le D; Clausen ME; Ciceron AC; Fuss C; Bennett B; Romm KF; Duan Z; Berg CJ
Health Educ Res; 2022 Nov; 37(6):379-392. PubMed ID: 36217613
[TBL] [Abstract][Full Text] [Related]
3. Selling cannabidiol products in Canada: A framing analysis of advertising claims by online retailers.
Zenone MA; Snyder J; Crooks V
BMC Public Health; 2021 Jul; 21(1):1285. PubMed ID: 34210299
[TBL] [Abstract][Full Text] [Related]
4. Availability and Promotion of Cannabidiol (CBD) Products in Online Vape Shops.
Leas EC; Moy N; McMenamin SB; Shi Y; Benmarhnia T; Stone MD; Trinidad DR; White M
Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34206501
[TBL] [Abstract][Full Text] [Related]
5. CBD (Cannabidiol) Product Attitudes, Knowledge, and Use Among Young Adults.
Wheeler M; Merten JW; Gordon BT; Hamadi H
Subst Use Misuse; 2020; 55(7):1138-1145. PubMed ID: 32093530
[No Abstract] [Full Text] [Related]
6. Use and Perceptions of Cannabidiol Products in Canada and in the United States.
Goodman S; Wadsworth E; Schauer G; Hammond D
Cannabis Cannabinoid Res; 2022 Jun; 7(3):355-364. PubMed ID: 33998872
[No Abstract] [Full Text] [Related]
7. Usage and health perception of cannabidiol-containing products among the population in Germany: a descriptive study conducted in 2020 and 2021.
Geppert J; Lietzow J; Hessel-Pras S; Kirsch F; Schäfer B; Sachse B
BMC Public Health; 2023 Nov; 23(1):2318. PubMed ID: 37996800
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol (CBD): Perspectives from Pinterest.
Merten JW; Gordon BT; King JL; Pappas C
Subst Use Misuse; 2020; 55(13):2213-2220. PubMed ID: 32715862
[TBL] [Abstract][Full Text] [Related]
9. The current understanding of the benefits, safety, and regulation of cannabidiol in consumer products.
Li J; Carvajal R; Bruner L; Kaminski NE
Food Chem Toxicol; 2021 Nov; 157():112600. PubMed ID: 34626752
[TBL] [Abstract][Full Text] [Related]
10. Cannabidiol use and perceptions in France: a national survey.
Casanova C; Ramier C; Fortin D; Carrieri P; Mancini J; Barré T
BMC Public Health; 2022 Aug; 22(1):1628. PubMed ID: 36038869
[TBL] [Abstract][Full Text] [Related]
11. Consumer perception, knowledge, and uses of cannabidiol.
Nguyen C; Moeller KE; McGuire M; Melton BL
Ment Health Clin; 2023 Oct; 13(5):217-224. PubMed ID: 38131055
[TBL] [Abstract][Full Text] [Related]
12. Cannabidiol: Knowledge, Beliefs, and Experiences of Patients With Cancer.
Butler TW; Hande K; Ryan M; Raman R; McDowell MR; Cones B; Jackson HJ; Cortez M; Murphy BA
Clin J Oncol Nurs; 2021 Aug; 25(4):405-412. PubMed ID: 34269337
[TBL] [Abstract][Full Text] [Related]
13. Safety and risks of CBD oils purchased online: unveiling uncertain quality and vague health claims.
Vida RG; Strauss LV; Bajtel Á; Kiss T; Csupor D; Fittler A
Front Pharmacol; 2023; 14():1273540. PubMed ID: 38192407
[No Abstract] [Full Text] [Related]
14. Cannabidiol and Other Cannabinoids: From Toxicology and Pharmacology to the Development of a Regulatory Pathway.
Koturbash I; MacKay D
J Diet Suppl; 2020; 17(5):487-492. PubMed ID: 32715797
[TBL] [Abstract][Full Text] [Related]
15. Expectations and knowledge of cannabidiol therapy for childhood epilepsy - A German caregiver survey.
Klotz KA; Schönberger J; Nakamura L; San Antonio-Arce V; Bast T; Wiemer-Kruel A; Schubert-Bast S; Borggraefe I; Syrbe S; Jacobs J
Epilepsy Behav; 2020 Oct; 111():107268. PubMed ID: 32645621
[TBL] [Abstract][Full Text] [Related]
16. The Role of Cannabidiol (CBD) in Chronic Pain Management: An Assessment of Current Evidence.
Boyaji S; Merkow J; Elman RNM; Kaye AD; Yong RJ; Urman RD
Curr Pain Headache Rep; 2020 Jan; 24(2):4. PubMed ID: 31980957
[TBL] [Abstract][Full Text] [Related]
17. Social media surveillance for perceived therapeutic effects of cannabidiol (CBD) products.
Tran T; Kavuluru R
Int J Drug Policy; 2020 Mar; 77():102688. PubMed ID: 32092666
[TBL] [Abstract][Full Text] [Related]
18. National survey identifying community pharmacist preceptors' experience, knowledge, attitudes, and behaviors influencing intent to recommend cannabidiol products.
Nichols MA; Arnett SJ; Fa B; Marchionda RA; Cutting MC; McDonald MR; Miller ML
J Am Pharm Assoc (2003); 2021; 61(4S):S91-S104. PubMed ID: 33558186
[TBL] [Abstract][Full Text] [Related]
19. Assessment of hemp oil-based cannabidiol use in a community-based pharmacy setting.
Gicewicz E; Gatewood SS; Kaefer TN; Nadpara P; Goode JR
J Am Pharm Assoc (2003); 2021; 61(4S):S49-S56. PubMed ID: 33745856
[TBL] [Abstract][Full Text] [Related]
20. Cannabidiol as a Treatment for Chronic Pain: A Survey of Patients' Perspectives and Attitudes.
Schilling JM; Hughes CG; Wallace MS; Sexton M; Backonja M; Moeller-Bertram T
J Pain Res; 2021; 14():1241-1250. PubMed ID: 33981161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
